Welcome to our dedicated page for DIH Holdings US SEC filings (Ticker: DHAI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking the FDA path of a robotic rehabilitation device while decoding revenue recognition rules can make DIH Holdings US (DHAI) filings feel like a clinical trial in patience. Each 10-K hides pages of R&D spend, device adoption metrics and virtual-reality software agreements, and every 8-K announces material events that may shift the competitive landscape overnight. Stock Titan turns those dense documents into clear takeaways, so you can stop combing through footnotes and start focusing on what moves the market.
Our platform automatically ingests every DIH Holdings US quarterly earnings report 10-Q filing, proxy statement executive compensation table and 8-K material events explained update the moment EDGAR posts them. AI-powered summaries surface where product revenue grew, how clinical studies progressed and whether new regulatory hurdles emerged—understanding DIH Holdings US SEC documents with AI is finally possible. Need real-time alerts on DIH Holdings US Form 4 insider transactions? We flag each executive stock move, complete with context, so you can gauge insider confidence without refreshing EDGAR all day.
Whether you’re asking, “What does DIH report in its annual report 10-K?” or searching for “DIH Holdings US earnings report filing analysis,” the answers live here. Explore:
- DIH Holdings US insider trading Form 4 transactions and real-time notifications
- Device sales trends inside the DIH Holdings US annual report 10-K simplified
- Segment margins and backlog in each DIH Holdings US quarterly earnings report 10-Q filing
- Board pay details from the DIH Holdings US proxy statement executive compensation schedule
- Regulatory breakthroughs in DIH Holdings US 8-K material events explained
DIH Holdings US, Inc. has filed a definitive proxy statement for a special meeting to be held September 25, 2025, describing five numbered proposals for stockholder vote. The proposals listed in the provided excerpts include a New Debenture NASDAQ Proposal, an Original Debenture Base Conversion Price Reduction Proposal regarding the company’s 8% Original Issue Discount Senior Secured Convertible Debentures, an Additional Investment Right Amendment Proposal, a Reverse Stock Split Proposal to amend the company’s certificate of incorporation to effect a reverse split of Class A Common Stock, and an Adjournment Proposal. The document includes proxy logistics such as virtual attendance instructions, toll-free and international dial-in numbers and a conference ID for the meeting, a proxy card, and signatures by the Chairman and CEO, Jason Chen. Vote thresholds referenced include majority votes and a requirement that holders of at least a majority of issued and outstanding shares present or represented vote "FOR" certain proposals.
DIH Holding US, Inc. is asking stockholders to approve five proposals at a virtual special meeting, principally to authorize the issuance and amendment of convertible debentures and warrants, and to permit a reverse stock split to regain Nasdaq compliance. The Company issued an 8% original-issue-discount senior secured convertible debenture on August 7, 2025, with aggregate face value of $2,222,222 (original issue discount $222,222), initially convertible at $0.25 per share and accompanied by a warrant to buy 8,888,888 shares at $0.25 (not exercisable until February 1, 2026); the debentures mature September 21, 2026 and pay 8% interest.
The proxy seeks approval under Nasdaq Rule 5635(d) because anti-dilution and price-adjustment features could cause conversion/exercise prices to be reduced (floor $0.10) and issuances to exceed 19.99% of outstanding shares. The proxy also seeks approval to reduce base conversion/warrant prices under the June 6, 2024 Original Debenture (outstanding principal $1,553,126), which could permit issuance of up to 10,616,304 additional shares and increase potential warrants to 19,800,000. Proposal 4 would authorize a reverse stock split up to 1-for-25 to address a Nasdaq notice received March 11, 2025 for failing to maintain a $1 minimum bid price. The Board unanimously recommends a vote FOR all proposals.
DIH Holding US sold an aggregate of $2,222,222 in principal of 8% Original Issue Discount senior secured convertible debentures, issued with a $222,222 original issue discount, resulting in approximately $2.0 million of gross proceeds and roughly $1.9 million net after offering expenses. The Debentures are initially convertible at $0.25 per share, subject to adjustment, and conversion is limited so a holder cannot exceed 9.99% beneficial ownership.
The Debentures mature in September 2026, carry an 8% annual rate with no interest payable during the first year and monthly redemptions beginning October 1, 2025 of $170,940.17 (payable in cash or, subject to formula limits, shares). Purchasers also received warrants for an aggregate of 8,888,888 shares at a $0.25 exercise price (five‑year term, exercisable February 1, 2026). The transaction includes registration rights covering the registrable securities and a voting agreement from Jason Chen in favor of required shareholder approvals.
DIH Holding US, Inc. (Nasdaq: DHAI) filed a Form 8-K reporting the 4 Aug 2025 appointment of Scott R. Burell to its Board of Directors. Burell, an experienced healthcare CFO now serving at AIVITA Biomedical and formerly at CombiMatrix during its sale to Invitae, joins as a Class III director with a term expiring at the 2026 annual meeting. He will also sit on the Audit, Compensation, and Nominating & Corporate Governance Committees, adding finance and transaction expertise to these key oversight bodies. The company noted no related-party transactions under Item 404 and did not disclose new compensatory arrangements. An accompanying press release (Ex. 99.1) dated 7 Aug 2025 announces the move. No other operational or financial updates were included.
FAQ
What is the current stock price of DIH Holdings US (DHAI)?
What is the market cap of DIH Holdings US (DHAI)?
